|
|
 |
|
Viewing report
|
|
 |
Acorda Therapeutics, Inc.
Sheila Greco Associates, May 2011, Pages: 2
Acorda Therapeutics, a privately-held biotechnology company, is developing therapies for SCI, MS and related nervous system disorders. In addition to Zanaflex, the Company`s lead clinical-stage product is Fampridine-SR, which is being developed in human c
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
 |
|
|